| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| AR protein | 11 | 0 | 0 | 11 |
| glucocorticoid receptor [Homo sapiens] | 7 | 0 | 0 | 7 |
| thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 6 | 0 | 0 | 6 |
| geminin | 7 | 0 | 0 | 7 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
| Mineralocorticoid receptor | 0 | 3 | 3 | 6 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
| Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
| TDP1 protein | 7 | 0 | 0 | 7 |
| estrogen nuclear receptor alpha | 11 | 0 | 0 | 11 |
| peroxisome proliferator activated receptor gamma | 5 | 0 | 0 | 5 |
| ATP-binding cassette sub-family C member 3 | 0 | 7 | 0 | 7 |
| Multidrug resistance-associated protein 4 | 0 | 7 | 0 | 9 |
| Bile salt export pump | 0 | 10 | 0 | 10 |
| Cellular tumor antigen p53 | 7 | 0 | 0 | 7 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
| Prostacyclin receptor | 0 | 1 | 1 | 2 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 2 | 2 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 2 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
| Canalicular multispecific organic anion transporter 1 | 0 | 6 | 0 | 6 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
| Atrial natriuretic peptide receptor 3 | 0 | 2 | 0 | 2 |
| Type-1A angiotensin II receptor | 0 | 4 | 2 | 6 |
| Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
| Type-1B angiotensin II receptor | 0 | 4 | 0 | 4 |
| Type-1 angiotensin II receptor | 0 | 4 | 3 | 9 |
| Type-2 angiotensin II receptor | 0 | 4 | 0 | 4 |
| Type-2 angiotensin II receptor | 0 | 3 | 0 | 3 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 6 | 0 | 0 | 6 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| thioredoxin reductase | 5 | 0 | 0 | 5 |
| phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| GLS protein | 3 | 0 | 0 | 3 |
| thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
| alpha-galactosidase | 2 | 0 | 0 | 2 |
| euchromatic histone-lysine N-methyltransferase 2 | 8 | 0 | 0 | 8 |
| cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
| chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
| flap endonuclease 1 | 4 | 0 | 0 | 4 |
| DNA polymerase iota isoform a (long) | 5 | 0 | 0 | 5 |
| muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
| lethal factor (plasmid) | 3 | 0 | 0 | 3 |
| Cytochrome P450 3A4 | 0 | 1 | 0 | 2 |
| Nitric oxide synthase, endothelial | 0 | 2 | 0 | 4 |
| Nitric oxide synthase, brain | 0 | 3 | 0 | 4 |
| Nitric oxide synthase, brain | 0 | 2 | 0 | 3 |
| Nitric oxide synthase, inducible | 0 | 2 | 0 | 3 |
| Nitric oxide synthase, inducible | 0 | 3 | 1 | 6 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 6 | 0 | 0 | 6 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
| regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
| Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
| D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
| lamin isoform A-delta10 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | 3 | 1 | 2 | 6 |
| Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
| Urease | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 2 | 4 |
| Beta-1 adrenergic receptor | 0 | 2 | 2 | 4 |
| Beta-3 adrenergic receptor | 0 | 0 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 1 | 2 | 6 |
| Gamma-aminobutyric acid receptor subunit delta | 3 | 1 | 2 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 1 | 2 | 6 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 1 | 2 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 1 | 2 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 1 | 2 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 1 | 2 | 6 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 1 | 2 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 1 | 2 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 1 | 2 | 6 |
| Alpha-1A adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-1B adrenergic receptor | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 1 | 2 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 1 | 2 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 1 | 2 | 6 |
| TAR DNA-binding protein 43 | 4 | 0 | 0 | 4 |
| Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
| GABA theta subunit | 3 | 1 | 2 | 6 |
| Gamma-aminobutyric acid receptor subunit epsilon | 3 | 1 | 2 | 6 |
| Atrial natriuretic peptide receptor 1 | 0 | 1 | 1 | 2 |
| Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
| GLI family zinc finger 3 | 8 | 0 | 0 | 8 |
| progesterone receptor | 5 | 0 | 0 | 5 |
| retinoic acid nuclear receptor alpha variant 1 | 9 | 0 | 0 | 9 |
| estrogen-related nuclear receptor alpha | 7 | 0 | 0 | 7 |
| Histone H2A.x | 4 | 0 | 0 | 4 |
| Voltage-dependent calcium channel gamma-2 subunit | 4 | 0 | 0 | 4 |
| Glutamate receptor 2 | 4 | 0 | 0 | 4 |
| Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
| Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
| Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
| Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| Microtubule-associated protein tau | 3 | 0 | 0 | 3 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 11 | 0 | 0 | 11 |
| Metallo-beta-lactamase type 2 | 0 | 1 | 1 | 2 |
| peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
| M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| Prothrombin | 0 | 1 | 0 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| Neprilysin | 0 | 1 | 0 | 1 |
| Neprilysin | 0 | 2 | 0 | 2 |
| Leukotriene A-4 hydrolase | 0 | 2 | 1 | 3 |
| EEF1AKMT4-ECE2 readthrough transcript protein | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 4 | 1 | 5 |
| Angiotensin-converting enzyme | 0 | 3 | 0 | 4 |
| Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Thymidine phosphorylase | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
| Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 4 |
| Endothelin-converting enzyme 1 | 0 | 1 | 0 | 1 |
| Succinyl-diaminopimelate desuccinylase | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Beta-lactamase TEM | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 0 | 1 | 1 |
| Beta-lactamase | 0 | 2 | 0 | 3 |
| Beta-lactamase | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme 2 | 0 | 2 | 0 | 2 |
| Beta-lactamase class B VIM-2 | 0 | 1 | 1 | 2 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 5 | 0 | 0 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 2 | 0 | 2 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 2 | 0 | 2 |
| Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| Chain A, Cruzipain | 2 | 0 | 0 | 2 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| PAX8 | 0 | 0 | 0 | 1 |
| RAR-related orphan receptor gamma | 8 | 0 | 0 | 8 |
| SMAD family member 2 | 3 | 0 | 0 | 3 |
| ATAD5 protein, partial | 2 | 0 | 0 | 2 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| SMAD family member 3 | 3 | 0 | 0 | 3 |
| STAT3, partial | 0 | 1 | 0 | 1 |
| Smad3 | 3 | 0 | 0 | 3 |
| estrogen receptor 2 (ER beta) | 5 | 0 | 0 | 5 |
| nuclear receptor subfamily 1, group I, member 3 | 3 | 0 | 0 | 3 |
| retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
| farnesoid X nuclear receptor | 5 | 0 | 0 | 5 |
| pregnane X nuclear receptor | 4 | 0 | 0 | 4 |
| 67.9K protein | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
| IDH1 | 3 | 0 | 0 | 3 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 5 | 0 | 0 | 5 |
| thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
| activating transcription factor 6 | 3 | 0 | 0 | 3 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 7 | 0 | 0 | 7 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform 2 | 5 | 0 | 0 | 5 |
| ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 4 | 0 | 0 | 4 |
| signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 2 |
| Interferon beta | 6 | 0 | 0 | 6 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 2 | 0 | 2 |
| Integrin beta-3 | 2 | 0 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 4 |
| Integrin alpha-IIb | 2 | 0 | 0 | 2 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 1 | 1 | 1 | 3 |
| Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 4 | 0 | 0 | 4 |
| Ataxin-2 | 4 | 0 | 0 | 4 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 3 | 0 | 3 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 4 | 0 | 4 |
| Endothelin-1 receptor | 0 | 1 | 0 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | 3 | 0 | 0 | 3 |
| EWS/FLI fusion protein | 4 | 0 | 0 | 4 |
| aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
| thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 12 | 0 | 2 | 0 | 3 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 1 | 0 | 6 | 0 | 7 |
| Carbonic anhydrase 2 | 0 | 6 | 0 | 7 |
| Albumin | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 4 | 0 | 3 | 0 | 4 |
| Carbonic anhydrase 6 | 0 | 3 | 0 | 4 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 7 | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 5 | 0 | 0 | 5 |
| Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 2 | 0 | 3 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 3 |
| G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 14 | 0 | 2 | 0 | 3 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 3 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 | 4 | 0 | 0 | 4 |
| arylsulfatase A | 2 | 0 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
| cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
| inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
| Cholecystokinin receptor type A | 1 | 0 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 1 | 0 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 1 | 2 |
| G | 4 | 0 | 0 | 4 |
| HLA class I histocompatibility antigen, B alpha chain | 4 | 0 | 0 | 4 |
| Thromboxane A2 receptor | 0 | 1 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 4 | 0 | 0 | 4 |
| Platelet glycoprotein VI | 0 | 1 | 1 | 3 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| cytochrome P450 2C9, partial | 4 | 0 | 0 | 4 |
| glp-1 receptor, partial | 3 | 0 | 0 | 3 |
| GALC protein | 1 | 0 | 0 | 1 |
| Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
| galanin receptor type 3 | 0 | 1 | 0 | 1 |
| survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
| Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
| Chain A, Ferritin light chain | 3 | 0 | 0 | 3 |
| Luciferase | 2 | 0 | 0 | 2 |
| T cell receptor, partial | 1 | 0 | 0 | 1 |
| luteinizing hormone receptor | 1 | 0 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| chaperonin-containing TCP-1 beta subunit homolog | 2 | 0 | 0 | 2 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
| Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| TSHR protein | 1 | 0 | 0 | 1 |
| Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
| caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
| polyprotein | 1 | 0 | 0 | 1 |
| luciferase | 1 | 0 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
| caspase-3 | 2 | 0 | 0 | 2 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
| caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| heat shock protein beta-1 | 3 | 0 | 0 | 3 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
| caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
| protein AF-9 isoform a | 0 | 0 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
| plasminogen precursor | 2 | 0 | 0 | 2 |
| urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
| Vpr | 1 | 0 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| replicative DNA helicase | 0 | 0 | 0 | 1 |
| recombinase A | 0 | 0 | 1 | 1 |
| POsterior Segregation | 0 | 0 | 1 | 1 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Glutathione reductase | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 1 | 0 | 2 |
| Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
| Albumin | 0 | 0 | 0 | 1 |
| Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
| Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
| Microtubule-associated protein tau | 0 | 1 | 1 | 2 |
| Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 1 | 3 |
| Cruzipain | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 1 | 0 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
| Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
| Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
| Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| Neutrophil elastase | 0 | 2 | 0 | 2 |
| Nitric oxide synthase, endothelial | 0 | 3 | 0 | 3 |
| Collagenase 3 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 2 | 0 | 2 |
| vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 0 | 0 | 1 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 1 | 0 | 2 |
| Proteinase-activated receptor 1 | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 1 | 2 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-2C adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Glucocorticoid receptor | 0 | 2 | 1 | 8 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| USP1 protein, partial | 1 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 1 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
| Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 2 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
| Polymerase acidic protein | 0 | 0 | 1 | 1 |
| Stromelysin-1 | 0 | 0 | 1 | 1 |
| Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 3 |
| Estrogen receptor | 0 | 0 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
| PINK1 | 1 | 0 | 0 | 1 |
| Parkin | 1 | 0 | 0 | 1 |
| photoreceptor-specific nuclear receptor | 0 | 1 | 0 | 1 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
| Insulin receptor | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Chain A, ykoF | 0 | 0 | 1 | 1 |
| Chain B, ykoF | 0 | 0 | 1 | 1 |
| Chain A, ThiT | 0 | 0 | 1 | 1 |
| Thiamine transporter ThiT | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
| Transketolase | 0 | 0 | 1 | 1 |
| Thiamine-binding periplasmic protein | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |